Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is... see more

TSXV:ARCH - Post Discussion

Arch Biopartners Inc > Should we enter phase 3....
View:
Post by stocksarefun on Oct 30, 2021 8:46am

Should we enter phase 3....

I have never owned a ticker that has moved from phase 2 to phase 3. 

For those who have been down this road before, what are the likely next steps?

- Is dilution and a big capital raise to fund the next next trials normal at these stages?
- How likely is it that the government of canada continue to grant funds?
- Does it require additional headcount?
- Is there another step between where we are at and launch of phase 3? (announcement of phase 3 design parameters, and disclosure of what's needed for it to commence, for example?)
- Does the announcement of Phase 3 and the announcement of funds being raised come in the same press release, of staggered?
- Do we generally see a wave of volume come in, simply by ARCH now being taken more seriously by US investors?

I'd love to start a discussion around what risks would present themselves in the short term, that could be used against us in creating wild volatile swings in the coming months as we progress down this path. 

Congratulations to everyone who has held on thus far.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities